These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15661745)

  • 1. Comparative agonist/antagonist responses in mutant human C5a receptors define the ligand binding site.
    Higginbottom A; Cain SA; Woodruff TM; Proctor LM; Madala PK; Tyndall JD; Taylor SM; Fairlie DP; Monk PN
    J Biol Chem; 2005 May; 280(18):17831-40. PubMed ID: 15661745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor.
    Buck E; Wells JA
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2719-24. PubMed ID: 15710877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An activation switch in the ligand binding pocket of the C5a receptor.
    Gerber BO; Meng EC; Dotsch V; Baranski TJ; Bourne HR
    J Biol Chem; 2001 Feb; 276(5):3394-400. PubMed ID: 11062244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
    Wong AK; Finch AM; Pierens GK; Craik DJ; Taylor SM; Fairlie DP
    J Med Chem; 1998 Aug; 41(18):3417-25. PubMed ID: 9719594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific disulfide capture of agonist and antagonist peptides on the C5a receptor.
    Buck E; Bourne H; Wells JA
    J Biol Chem; 2005 Feb; 280(6):4009-12. PubMed ID: 15550394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the ligand-binding site on the C5a receptor: arginine74 of C5a contacts aspartate282 of the C5a receptor.
    Cain SA; Coughlan T; Monk PN
    Biochemistry; 2001 Nov; 40(46):14047-52. PubMed ID: 11705397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity.
    March DR; Proctor LM; Stoermer MJ; Sbaglia R; Abbenante G; Reid RC; Woodruff TM; Wadi K; Paczkowski N; Tyndall JD; Taylor SM; Fairlie DP
    Mol Pharmacol; 2004 Apr; 65(4):868-79. PubMed ID: 15044616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of C5a receptor agonists from phage display libraries.
    Cain SA; Higginbottom A; Monk PN
    Biochem Pharmacol; 2003 Nov; 66(9):1833-40. PubMed ID: 14563493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptor.
    Cain SA; Woodruff TM; Taylor SM; Fairlie DP; Sanderson SD; Monk PN
    Biochem Pharmacol; 2001 Jun; 61(12):1571-9. PubMed ID: 11377387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding.
    Scola AM; Higginbottom A; Partridge LJ; Reid RC; Woodruff T; Taylor SM; Fairlie DP; Monk PN
    J Biol Chem; 2007 Feb; 282(6):3664-71. PubMed ID: 17158873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric receptors of the human C3a receptor and C5a receptor (CD88).
    Crass T; Ames RS; Sarau HM; Tornetta MA; Foley JJ; Köhl J; Klos A; Bautsch W
    J Biol Chem; 1999 Mar; 274(13):8367-70. PubMed ID: 10085065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of the gerbil C5a receptor and identification of a transmembrane domain V amino acid that is crucial for small molecule antagonist interaction.
    Waters SM; Brodbeck RM; Steflik J; Yu J; Baltazar C; Peck AE; Severance D; Zhang LY; Currie K; Chenard BL; Hutchison AJ; Maynard G; Krause JE
    J Biol Chem; 2005 Dec; 280(49):40617-23. PubMed ID: 16230349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor.
    Raffetseder U; Röper D; Mery L; Gietz C; Klos A; Grötzinger J; Wollmer A; Boulay F; Köhl J; Bautsch W
    Eur J Biochem; 1996 Jan; 235(1-2):82-90. PubMed ID: 8631370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.
    Bock D; Martin U; Gärtner S; Rheinheimer C; Raffetseder U; Arseniev L; Barker MD; Monk PN; Bautsch W; Köhl J; Klos A
    Eur J Immunol; 1997 Jun; 27(6):1522-9. PubMed ID: 9209506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin.
    Chen Z; Zhang X; Gonnella NC; Pellas TC; Boyar WC; Ni F
    J Biol Chem; 1998 Apr; 273(17):10411-9. PubMed ID: 9553099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus.
    Monk PN; Barker MD; Partridge LJ; Pease JE
    J Biol Chem; 1995 Jul; 270(28):16625-9. PubMed ID: 7622471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
    Tardif M; Brouchon L; Rabiet MJ; Boulay F
    Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
    Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
    J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage of the human C5A receptor by proteinases derived from Porphyromonas gingivalis: cleavage of leukocyte C5a receptor.
    Jagels MA; Ember JA; Travis J; Potempa J; Pike R; Hugli TE
    Adv Exp Med Biol; 1996; 389():155-64. PubMed ID: 8861006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of protein kinase C-mediated phosphorylation of the complement C5a receptor on serine 334.
    Pollok-Kopp B; Hüttenrauch F; Rethorn S; Oppermann M
    J Biol Chem; 2007 Feb; 282(7):4345-4353. PubMed ID: 17145764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.